Differential polyamine analogue effects in four human breast cancer cell lines

Toxicology

Volumn 223, Issue 1-2, 2006, Pages 71-81

  Holst, C Martina ^a   Frydman, Benjamin ^c   Marton, Laurence J ^b   Oredsson, Stina M ^a  

^a LUND UNIVERSITY   (Sweden)

^b Cellgate Incorporated   (United States)

^c NONE

Author keywords

Cell death; CGC 11047; CGC 11093; CGC 11158; Human breast cancer; Polyamine analogues

Indexed keywords

POLYAMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; POLYAMINES; SPERMINE;

EID: 33646597294     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.009     Document Type: Article

References (45)

1. Bacchi C.J., Weiss L.M., Lane S., Frydman B., Valasinas A., Reddy V.K., Sun J.S., Marton L.J., Khan I.A., Moretto M., Yarlett N., and Wittner M. Novel synthetic polyamines are effective in the treatment of experimental Microsporidiosis, an opportunistic AIDS-associated infection. Antimicrob. Agents Chemother. 46 (2002) 55-61
2. Basu H.S., Pellarin M., Feuerstein B.G., Shirahata A., Sameijma K., Deen D.F., and Marton L.J. Interaction of a polyamine analogue 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res. 53 (1993) 3948-3955
3. Basu H.S., Wright W.D., Deen D.F., Roti-Roti J., and Marton L.J. Treatment with a polyamine analogue alters DNA matrix association in HeLa cell nuclei: a nucleoid halo assay. Biochemistry 32 (1993) 4073-4076
4. 1-acetyltransferase-the turning point in polyamine metabolism. FASEB J. 7 (1993) 653-661
5. Casero R.A., and Woster P.M. Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44 (2001) 1-26
6. Chen Y., Kramer D.L., Diegelman P., Vujcic S., and Porter C.W. Apoptotic signalling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res. 61 (2001) 6437-6444
7. 11-diethylnorspermine in patients with advanced malignancy. Invest. New Drugs 15 (1997) 227-234
8. Davidson N.E., Hahm H.A., McCloskey D.E., Woster P.M., and Casero R.A. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endorine-Related Cancer 6 (1999) 69-73
9. Denziot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89 (1986) 271-277
10. Fayer R., Speer C.A., and Dubey J.P. The general biology of Cryptosporidium. In: Frayer R. (Ed). Cryptosporidium and Cryptosporidiosis (1995), CRC Press, Boca Raton 1-42
11. Feuerstein B.G., Pattabiraman N., and Marton L.J. Molecular mechanics of the interactions of spermine with DNA: DNA bending as a result of ligand binding. Nucl. Acids Res. 18 (1990) 1271-1282
12. Fredlund J.O., Johansson M., Baldetorp B., and Oredsson S.M. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique. Cell Prolif. 90 (1994) 425-435
13. Fricker S.P., and Buckley R.G. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents. Anticancer Res. 16 (1996) 3755-3760
14. Frydman B., Blokhin A.V., Brummel S., Wilding G., Maxuitenko Y., Sarkar A., Bhattacharya S., Church D., Reddy V.K., Kink J.A., Marton L.J., Valasinas A., and Basu H.S. Cyclopropane-containing polyamine analogues are efficient growth inhibitors of human prostate tumor xenograft in nude mice. J. Med. Chem. 46 (2003) 4586-4600
15. Frydman B., Porter C.W., Maxuitenko Y., Sarkar A., Bhattacharya S., Valasinas A., Reddy V.K., Kisiel N., Marton L.J., and Basu H.S. A novel polyamine analogue (SL-11093) inhibits growth of human prostate tumor xenograft in nude mice. Cancer Chemother. Pharmacol. 51 (2003) 488-492
16. 11-diethylnorspermine in patients with non-small cell lung cancer. Clin. Cancer Res. 8 (2002) 684-690
17. Hegardt C., Johannsson O.T., and Oredsson S.M. Rapid caspase-dependent cell death in human breast cancer cells induced by a polyamine analogue. Eur. J. Biochem. 269 (2002) 1033-1039
18. Holst C.M., and Oredsson S.M. Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of a spermine analogue on human breast cancer cell lines. Toxicol. In Vitro 19 (2005) 379-387
19. Hu R.-H., and Pegg A.E. Rapid induction of apoptosis by deregulated uptake of polyamine analogues. Biochem. J. 328 (1997) 307-316
20. Huang Y., Hager E.R., Phillips D.L., Dunn V.R., Hacker A., Frydman B., Kink J.A., Valasinas A.L., Reddy V.K., Marton L.J., Casero R.A., and Davidson N.E. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin. Cancer Res. 9 (2003) 2769-2777
21. Johannsson O.T., Staff S., Vallon-Christersson J., Kytöla S., Gudjonsson T., Rennstam K., Hedenfalk I.A., Adeyinka A., Kjéllen E., Wennerberg J., Baldetorp B., Petersen O.W., Olsson H., Oredsson S., Isola J., and Borg A. Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab. Invest. 83 (2003) 387-396
22. Kramer D.L., Fogel-Petrovic M., Diegelmann P., Cooley J.M., Bernacki R.J., McManis J.S., Bergeron R.J., and Porter C.W. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res. 57 (1997) 5521-5527
23. WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Cancer Res. 59 (1999) 693-698
24. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Fohlin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
25. Mitchell J.L.A., Leyser A., Holtorff M.S., Bates J.S., Frydman B., Valasinas A.L., Reddy V.K., and Marton L.J. Antizyme induction by polyamine analogues as a factor of cell growth inhibition. Biochem. J. 366 (2002) 663-671
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65 (1983) 55-63
27. Nitta T., Igarashi K., Yamashita A., and Yamamoto N. Polyamine depletion induces apoptosis through mitochondria-mediated pathway. Exp. Cell. Res. 276 (2002) 120-128
28. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment on mammalian cell cytotoxicity. Eur. J. Biochem. 367 (2000) 5421-5426
29. Peterson G.L. Review of the Folin phenol protein quantitation method of Lowry, Rosenburgh, Farr and Randall. Anal. Biochem. 100 (1979) 201-220
30. 11-bis(ethyl)norspermine against human melnoma xenografts and possible biochemical correlates of drug action. Cancer Res. 53 (1991) 581-586
31. 12-bisethylspermine-synthesis and growth inhibitory effects on human tumour cell lines. J. Med. Chem. 41 (1998) 4723-4732
32. Sapan C.V., Lundblad R.L., and Price N.C. Colorimetric protein assay techniques. Biotechnol. Appl. Biochem. 29 (1999) 99-108
33. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targ. 4 (2003) 537-564
34. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr. Drug Targ. 4 (2003) 565-585
35. Seiler N., and Knödgen B. Determination of polyamines and related compounds by reversed-phase high-performance liquid chromatography: improved separation systems. J. Chromatogr. Biomed. Appl. 339 (1985) 45-57
36. Stevens L. Buffers and the determination of protein concentrations. In: Eisenthal R., and Danson M. (Eds). Enzyme Assays: A Practical Approach (1992), IRL Press, Oxford 316-335
37. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58 (2001) 244-258
38. Thornthwaite J.T., Sugarbaker E.V., and Temple W.J. Preparation of tissues for DNA flow cytometric analysis. Cytometry 1 (1980) 229-237
39. Tomlinson G.E., Chen T.T.-L., Stastny V.A., Virmani A.K., Spillman M.A., Tonk V., Blum J.L., Schneider N.R., Wistuba I.I., Shay J.W., Minna J.D., and Gazdar A.F. Characterization of a breast cancer cell line derived from a germ-line BRCAI mutation carrier. Cancer Res. 58 (1998) 3237-3242
40. Valasinas A., Reddy V.K., Blokhin A.V., Basu H.S., Bhattacharya S., Sarkar A., Marton L.J., and Frydman B. Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cells. Bioorg. Med. Chem. 11 (2003) 4121-4131
41. 14-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells. J. Med. Chem. 44 (2001) 390-403
42. 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J. Biol. Chem. 275 (2000) 38319-38328
43. Wallace H.M., Fraser A., and Hughes A. A perspective of polyamine metabolism. Biochem. J. 376 (2003) 1-14
44. 12N]Bis(ethyl)-cis-6,7-dehydrospermine: a new drug treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha. Antimicrob. Agents Chemother. 44 (2000) 2891-2894
45. Zagaja G.P., Shrivastav M., Flieg M.J., Marton L.J., Rinker-Schaeffer C.W., and Dolan M.E. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother. Pharmacol. 41 (1998) 505-512